The letter

One letter a week, in your inbox.

The week's signal, what shipped, what is worth running tonight, and the editor's note. No tracking, no ads, nothing else.

We keep your address, your language and the date you joined, nothing else. Every letter has a one-click unsubscribe link that deletes the record.

← Accept All   Archive
Tech.euEurope

Berlin’s Apheris and Ginkgo bring pharma giants together to train AI on 10,000 antibodies

September 29

Ginkgo Datapoints and Berlin-based Apheris today announced that the Antibody Developability Consortium has kicked off with its founding members.

Read at Tech.eu ↗

More from Tech.eu on Accept All

More from Tech.eu on Accept All.